Genesco (GCO) Tops Q2 EPS by 38c ; Offers Guidance
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $35.50 --0%
Revenue Growth %: -3.2%
Financial Fact:
Cost of sales: 355.19M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Revenue Growth %: -3.2%
Financial Fact:
Cost of sales: 355.19M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q2 EPS of ($0.85), $0.38 better than the analyst estimate of ($1.23). Revenue for the quarter came in at $523.03 million versus the consensus estimate of $497.25 million.
GUIDANCE:
Genesco sees FY2024 EPS of $2.00-$2.50, versus the consensus of $2.23.
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
